Precision Medicine in Sepsis and Septic Shock.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

1. A 2004-2025 Bibliometric Study of Genetic Variation and Multiomics Biomarkers in Sepsis Based on 940 Publications.Human mutation · 2026
   Review
2. Phenotypic Characterization of Intensive Care Patients With Infections: A Pilot Study of Host and Pathogen-Based Cluster Analysis.Cureus · 2024
   Article
3. Advances and Challenges in Sepsis Management: Modern Tools and Future Directions.Cells · 2024
   Review
4. Clinical value of CVP+VIVC in predicting fluid resuscitation in patients with septic shock.African health sciences · 2023
   Observational
5. Clinical Sepsis Phenotypes in Critically Ill Patients.Microorganisms · 2023
   Review
6. A Bayesian genomic-enhanced precision critical care early warning model for septic shock outcomes.International journal of critical illness and injury science
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract